Krämer H, Deger A, Koch R, Rapp R, Hinz M, Weber U
Biol Chem Hoppe Seyler. 1987 May;368(5):471-9. doi: 10.1515/bchm3.1987.368.1.471.
Insulin receptors from rat liver membranes were labelled with a 125I-labelled photoreactive insulin analogue or by iodination using lactoperoxidase and analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Under nonreducing conditions different receptor forms with Mr 400,000 (alpha 2 beta 2), 360,000 (alpha 2 beta beta'), 330,000 (alpha 2 beta' beta'), 320,000 (alpha 2 beta), 280,000 (alpha 2 beta'), 240,000 (alpha 2), 210,000 (alpha beta), 165,000 (alpha beta') and 115,000 (alpha) were detected. The subunit composition of these receptor forms was determined by two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis in the absence and presence of dithioerythritol. During denaturation in sodium dodecyl sulfate in the absence of reductants, the Mr 400,000 receptor form (alpha 2 beta 2) was converted into the Mr 320,000 (alpha 2 beta) and Mr 240,000 (alpha 2) receptor form. This conversion was prevented either by N-ethylmaleimide, oxidants, or low pH. In contrast, alkylation of the receptor with N-ethylmaleimide under non-denaturing conditions did not prevent the appearance of intermediate-sized receptor forms. Furthermore, the inhibition of receptor cleavage by N-ethylmaleimide during denaturation was also observed when the amount of free sulfhydryl groups was reconstituted by the addition of an unlabelled and non-alkylated receptor sample to the alkylated and photoaffinity-labelled receptor. These results suggest, that the generation of different oligomeric receptor forms detected by sodium dodecyl sulfate polyacrylamide gel electrophoresis is due at least in part to the cleavage of one or both beta-subunits from the insulin receptor.(ABSTRACT TRUNCATED AT 250 WORDS)
用125I标记的光反应性胰岛素类似物标记大鼠肝细胞膜上的胰岛素受体,或用乳过氧化物酶碘化法进行标记,然后通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳进行分析。在非还原条件下,检测到不同分子量的受体形式,分别为400,000(α2β2)、360,000(α2ββ')、330,000(α2β'β')、320,000(α2β)、280,000(α2β')、240,000(α2)、210,000(αβ)、165,000(αβ')和115,000(α)。在有无二硫苏糖醇的情况下,通过二维十二烷基硫酸钠聚丙烯酰胺凝胶电泳确定这些受体形式的亚基组成。在没有还原剂的情况下,在十二烷基硫酸钠中变性时,分子量为400,000的受体形式(α2β2)转化为分子量为320,000(α2β)和240,000(α2)的受体形式。N-乙基马来酰亚胺、氧化剂或低pH可阻止这种转化。相反,在非变性条件下用N-乙基马来酰亚胺使受体烷基化,并不阻止中等大小受体形式的出现。此外,当通过向烷基化和光亲和标记的受体中加入未标记且未烷基化的受体样品来重建游离巯基的量时,在变性过程中也观察到N-乙基马来酰亚胺对受体裂解的抑制作用。这些结果表明,通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳检测到的不同寡聚体受体形式的产生至少部分是由于胰岛素受体的一个或两个β亚基的裂解。(摘要截短至250字)